The Vertical Group
Venture capitalBerkeley Heights · Pre-Seed–Series B · 4 people tracked
Investment thesis
The Vertical Group invests in healthcare and medical device companies that demonstrate both improved patient outcomes and cost-effectiveness in the medical care system. Leveraging deep operational expertise in medical device and biotech industries—including sales, marketing, research, development, and regulatory affairs—the firm identifies opportunities created by lower market entry costs and reduced competition following other investors' retreat from the sector. The firm participates in early-stage angel and venture financings across multiple stages.
Source: firm website, verified Jul 21, 2026.
Team · 4 people
from the firm's website
Veteran healthcare venture capital investor with 40 years of experience in medical device and life sciences investments. Former corporate attorney and past chairman of the NVCA's Medical Industry Group who has served on boards of over 30 medical companies.
Healthcare investment executive with over 30 years in law, asset management, and regulatory affairs. Co-founder of Paddington Partners and former law partner at Webster & Sheffield who has served on boards of medical device and healthcare companies.
Investment professional with over 30 years of healthcare industry experience across venture capital, investment research, and investment banking. Recognized healthcare expert who has served on boards of numerous medical device and healthcare companies.
Physician and healthcare executive with over 15 years of experience as an interventional cardiologist and medical device industry leader. Previously held senior management roles at Abbott Laboratories overseeing medical device development and currently serves as founder and CEO of Route 92 Medical.
What they invest in
from 6 of 16 portfolio companiesMedical Devices ×3Healthtech ×2Advanced Manufacturing ×1Biotech ×1Deep Tech ×1Digital Health ×1Enterprise Software ×1Hardware ×1
HQs:United States×2
Investments · 16 tracked
founders shown can be your intro pathCustomDyn provides design, engineering, and fabrication services across multiple materials including steel, aluminum, wood, and plastics. The company also offers production planning, consulting, and equipment services for events, photography, videography, and media projects.
Advanced ManufacturingHardware
Monteris develops minimally invasive laser ablation technology for treating brain tumors and drug-resistant epilepsy. The company serves neurosurgeons and hospitals in the medical device and oncology markets.
Deep TechMedical Devices
Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations. The company develops digital diabetes prevention programs, musculoskeletal care, and behavior change interventions to reduce healthcare costs and improve health outcomes.
Digital HealthHealthtechWellness & Fitness
Mereo BioPharma develops therapies for rare genetic diseases, including osteogenesis imperfecta and alpha-1 antitrypsin deficiency-associated lung disease, operating with a capital-efficient model through strategic partnerships.
Biotech
Outset develops an enterprise dialysis system for hospitals and health systems to insource acute dialysis care. The solution includes a hemodialysis device, data analytics platform with EMR integration, and comprehensive clinical and operational support services.
Enterprise SoftwareHealthtechMedical Devices
Tornier is a medical device manufacturer specializing in orthopedic and neurosurgical equipment, including shoulder replacement systems, spine solutions, and surgical instruments for hospitals and healthcare providers.
Medical Devices
Board seats · per SEC filings
what is this? ⓘ$50M raise · filed Apr 2026 · via Jack W. Lasersohn
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does The Vertical Group invest at?
- The Vertical Group invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is The Vertical Group's typical check size?
- The Vertical Group typically writes checks of $250K – $5M.
- What sectors does The Vertical Group focus on?
- The Vertical Group focuses on Biotech, Digital Health, Medical Devices.
- Where is The Vertical Group located?
- The Vertical Group is headquartered in Berkeley Heights, US.
Images
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
A European investment firm established in 2016 by former Index Ventures life sciences professionals with over 20 years of experience in drug discovery and therapeutic development for unmet medical needs.